BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12523936)

  • 1. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
    Zelcer N; Reid G; Wielinga P; Kuil A; van der Heijden I; Schuetz JD; Borst P
    Biochem J; 2003 Apr; 371(Pt 2):361-7. PubMed ID: 12523936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
    Chen ZS; Guo Y; Belinsky MG; Kotova E; Kruh GD
    Mol Pharmacol; 2005 Feb; 67(2):545-57. PubMed ID: 15537867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).
    Hirohashi T; Suzuki H; Takikawa H; Sugiyama Y
    J Biol Chem; 2000 Jan; 275(4):2905-10. PubMed ID: 10644759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H; Liu G; Rea PA; Kruh GD
    Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.
    Loe DW; Almquist KC; Cole SP; Deeley RG
    J Biol Chem; 1996 Apr; 271(16):9683-9. PubMed ID: 8621644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
    Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
    Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
    Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
    Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
    Leslie EM; Ito K; Upadhyaya P; Hecht SS; Deeley RG; Cole SP
    J Biol Chem; 2001 Jul; 276(30):27846-54. PubMed ID: 11375986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
    Chen ZS; Hopper-Borge E; Belinsky MG; Shchaveleva I; Kotova E; Kruh GD
    Mol Pharmacol; 2003 Feb; 63(2):351-8. PubMed ID: 12527806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
    Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
    Bodo A; Bakos E; Szeri F; Varadi A; Sarkadi B
    J Biol Chem; 2003 Jun; 278(26):23529-37. PubMed ID: 12704183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCC10, ABCC11, and ABCC12.
    Kruh GD; Guo Y; Hopper-Borge E; Belinsky MG; Chen ZS
    Pflugers Arch; 2007 Feb; 453(5):675-84. PubMed ID: 16868766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.
    Rius M; Hummel-Eisenbeiss J; Hofmann AF; Keppler D
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G640-9. PubMed ID: 16282361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
    Zelcer N; Saeki T; Bot I; Kuil A; Borst P
    Biochem J; 2003 Jan; 369(Pt 1):23-30. PubMed ID: 12220224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
    Järvinen E; Troberg J; Kidron H; Finel M
    Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
    Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW; Gu HM; Vasa M; Muredda M; Cole SP; Deeley RG
    Biochemistry; 2003 Aug; 42(33):9989-10000. PubMed ID: 12924948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.
    Wittgen HG; van den Heuvel JJ; van den Broek PH; Dinter-Heidorn H; Koenderink JB; Russel FG
    Drug Metab Dispos; 2011 Jul; 39(7):1294-302. PubMed ID: 21511945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.